Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10 Supply Disruption — Fusion IV Pharmaceuticals, In
Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10 Supply Disruption — Fusion IV Pharmaceuticals, In is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10; Manufacturer: Fusio
| Drug name | Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10 |
|---|---|
| Manufacturer | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0971-2020 |
| Initiation date | 20200115 |
| Quantity affected | N/A |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →